Literature DB >> 18159357

Hepatitis.

M Krajden.   

Abstract

Entities:  

Year:  2001        PMID： 18159357      PMCID： PMC2094844          DOI： 10.1155/2001/428059

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  18 in total

1.  Chronic hepatitis B: new therapies on the horizon?

Authors:  S Pianko; J McHutchison
Journal:  Lancet       Date:  1999-11-13       Impact factor: 79.321

2.  Both a 'magic bullet' and good aim are required to link public health interests and health care needs in HIV infection.

Authors:  G P Garnett; L M Bartley; D W Cameron; R M Anderson
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

Review 3.  Effect of hepatitis B virus mutants on efficacy of vaccination.

Authors:  A J Zuckerman
Journal:  Lancet       Date:  2000-04-22       Impact factor: 79.321

Review 4.  Management of viral hepatitis: clinical and public health perspectives--a consensus statement. CASL Hepatitis Consensus Group. Canadian Association for Study of the Liver.

Authors:  M Sherman
Journal:  Can J Gastroenterol       Date:  1997 Jul-Aug       Impact factor: 3.522

5.  Transmission of hepatitis C virus in a gynecological surgery setting.

Authors:  M Massari; N Petrosillo; G Ippolito; L Solforosi; L Bonazzi; M Clementi; A Manzin
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

6.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

7.  Treatment of acute hepatitis C with interferon alfa-2b.

Authors:  E Jaeckel; M Cornberg; H Wedemeyer; T Santantonio; J Mayer; M Zankel; G Pastore; M Dietrich; C Trautwein; M P Manns
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

8.  Costs of hepatitis C.

Authors:  J P Leigh; C L Bowlus; B N Leistikow; M Schenker
Journal:  Arch Intern Med       Date:  2001-10-08

9.  Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Authors:  Y F Liaw; N W Leung; T T Chang; R Guan; D I Tai; K Y Ng; R N Chien; J Dent; L Roman; S Edmundson; C L Lai
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

10.  A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Authors:  C L Lai; R N Chien; N W Leung; T T Chang; R Guan; D I Tai; K Y Ng; P C Wu; J C Dent; J Barber; S L Stephenson; D F Gray
Journal:  N Engl J Med       Date:  1998-07-09       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.